суббота, 24 декабря 2016 г.

FDA OKs first treatment for rare genetic disorder

FDA OKs first treatment for rare genetic disorder


The Food and Drug Administration has approved the first treatment for children and adults with spinal muscular atrophy, a rare genetic disorder marked by progressive muscle weakness that's the most common genetic cause of death in infants.



from Biotech News